Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders
- 1 June 2000
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 109 (4), 865-869
- https://doi.org/10.1046/j.1365-2141.2000.02067.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Evaluation of the effectiveness of DDAVP in surgery and in bleeding episodes in haemophilia and von Willebrand's disease. A study on 43 patientsClinical and Laboratory Haematology, 2008
- Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 YearsBlood, 1997
- Review of clinical experience of desmopressin in patients with congenital and acquired bleeding disordersEuropean Journal of Anaesthesiology, 1997
- Desmopressin - a haemostatic drugEuropean Journal of Anaesthesiology, 1997
- DDAVP‐induced enhancement of platelet retention: Its dependence on platelet‐von Willebrand Factor and the platelet receptor GP IIb/IIIaEuropean Journal of Haematology, 1992
- Use of DDAVP in inherited and acquired platelet dysfunctionAmerican Journal of Hematology, 1990
- Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders [see comments]Blood, 1988
- Response of Factor VIII/von Willebrand Factor to DDAVP in Healthy Subjects and Patients with Haemophilia A and von Willebrand's DiseaseBritish Journal of Haematology, 1981
- 1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASEThe Lancet, 1977
- Mechanism of Plasminogen Activator and Factor VIII Increase after Vasoactive DrugsBritish Journal of Haematology, 1975